Long-term safety of filgrastim (rhG-CSF) administration: application of haematopoietic growth factors in healthy individuals

Br J Haematol. 2007 Apr;137(1):78-9; author reply 79-80. doi: 10.1111/j.1365-2141.2007.06529.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Filgrastim
  • Granulocyte Colony-Stimulating Factor / adverse effects*
  • Granulocyte Colony-Stimulating Factor / pharmacology
  • Hematologic Neoplasms / etiology
  • Hematopoietic Stem Cell Mobilization*
  • Humans
  • Peripheral Blood Stem Cell Transplantation
  • Recombinant Proteins
  • Risk
  • Time Factors
  • Tissue Donors*

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Filgrastim